Jak1 selective inhibitors and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO RE49834
SERIAL NO

17526799

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The new 1H-furo[3,2-b]imidazo[4,5-d]pyridine derivatives are selective Jak1 kinase inhibitors useful in treating disorders related to Jak1 activities such as autoimmune diseases or disorders, inflammatory diseases or disorders, and cancer or neoplastic diseases or disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANGZHOU HIGHLIGHTII PHARMACEUTICAL CO LTDROOM 301 NO 4 BLDG HEXIANG SCIENCE & TECHNOLOGY CENTER QIANTANG DISTRICT HANGZHOU 310018

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liang, Congxin Palm Beach Gardens, US 59 673

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 13, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00